PURE CANNABIS OIL LEGAL. This presentation does not constitute an - - PowerPoint PPT Presentation

▶

Feb 14, 2023 282 likes •432 views

CORPORATE PRESENTATION Q2 2019 PURE CANNABIS OIL LEGAL. This presentation does not constitute an offer of any securities for sale or a information contained in this Presentation is based on certain assumptions solicitation of an offer to

SLIDE 1

PURE CANNABIS OIL

CORPORATE PRESENTATION Q2 2019

SLIDE 2

LEGAL.

This presentation does not constitute an offer of any securities for sale or a solicitation of an offer to purchase any securities. This Presentation, and the information contained herein, is not for release, distribution or publication into

r in the United States or any other jurisdiction where applicable laws prohibit

its release, distribution or publication. This Presentation is dated June 2019 and is being issued by Pure Extract Technologies Inc. (the “Company”) for information purposes only. It is information in a summary form and does not purport to be complete. All historical financial and operational performance descriptions are unaudited and refer to use of the Pure Pulls brand prior to its acquisition by the Company. No representation or warranty, express or implied, is made or given by or on behalf of the Company or any of its affiliates, directors, officers or employees as to the accuracy, completeness or fairness of the information or opinions contained in this presentation and no responsibility or liability is accepted by any person for such information or opinions. The Company does not undertake

r agree to update this presentation or to correct any inaccuracies in, or
missions from, this Presentation that may become apparent. No person has

been authorized to give any information or make any representations other than those contained in this presentation and, if given and/or made, such information or representations must not be relied upon as having been so authorized. The contents of this Presentation are confidential and may not be copied, distributed, published or reproduced in whole or in part, or disclosed or distributed by recipients to any other person. No reliance may be placed for any purpose whatsoever on the information or opinions contained in this Presentation or on its completeness, accuracy or fairness. No person should treat the contents of this Presentation as advice relating to legal, taxation

r investment matters, and must make their own assessments concerning

these and other consequences of investing in securities of the Company, including the merits of investing and the risks. Prospective investors are advised to consult their own personal legal, tax and accounting advisors and to conduct their own due diligence and agree to be bound by the limitations

f this disclaimer.

Certain statements in this Presentation may constitute forward-looking information within the meaning of applicable securities laws. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “expects,” “believes,” “anticipates,” “budget,“ scheduled,” “estimates,” “forecasts,” “intends,” “plans,” and variations of such words and phrases, or by statements that certain actions, events or results “may,” “will,” “could,” “would,” or “might,” “be taken,” “occur,” or “be achieved.” Certain statements, beliefs and opinions in this Presentation (including those contained in graphs, tables and charts), which reflect the Company’s or, as appropriate, the Company’s directors’ current expectations and projections about future events, constitute forward-looking information. Forward-looking information contained in this Presentation is based on certain assumptions regarding, among other things, expected growth, results of operations, performance, industry trends and growth opportunities. While management considers these assumptions to be reasonable, based on information available, they may prove to be incorrect. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and other factors include, but are not limited to risks associated with the Company’s ability to obtain offtake orders based on projected market rates of products, meet historic sales performances, and its ability to implement and fulfill its business strategies including obtaining a Standard Processing License and expansion plans for building extraction facilities; general economic conditions; adverse industry events; marketing costs; loss of markets; future legislative and regulatory developments, including any limitations on branding of cannabis products; inability to access sufficient capital from internal and external sources, and/or inability to access sufficient capital on favourable terms; income tax and regulatory matters; the ability of the Company to implement its business strategies including expansion plans; competition; and changes in regulation. The foregoing factors are not intended to be exhaustive. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. Forward-looking statements contained in this Presentation regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. The Company does not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. This presentation includes financial outlook about the Company’s prospective capacity, which is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraphs. Capacity estimates contained in this presentation were made by management as of the date

f this presentation and are provided for the purpose of describing the

anticipated capacity of Company’s facilities following expansion, and are not a revenue projection or an estimate of actual profitability or any other measure

f financial performance. Readers are cautioned that the financial outlook

contained in this document should not be used for purposes other than for which it is disclosed herein. Information in this presentation regarding competing businesses was

btained from public sources and has not been verified by the Company. There

are risks in making an investment decision based on these competitors and potential investors should carefully review these competitors. Many of the Company’s competitors and potential competitors are larger and have greater name recognition, longer operating histories, larger marketing budgets and significantly greater resources than the Company does.

SLIDE 3

LEADERS IN EXTRACTION.

Pure Extracts facility in Pemberton, BC will be EU-GMP Certified and produce the first brands sold under the Cannabis Act including Canada’s most recognized brand; Pure Pulls.

Previously selling approx. per month Phase I expansion capacity of per month in revenue Phase II expansion capacity of per month in revenue

*$800,000 $5,000,000 $20,000,000

*unaudited historical sales of product under the Pure Pulls brand prior to the brand’s acquisition by Pure Extracts

SLIDE 4

MARKET OPPORTUNITY .

No dominant brands in cannabis sector Cannabis extractors at infancy of development Shifting opportunity as Canada’s cannabis markets are currently dominated by dried flower products, with only an estimated 13% market share by extract products. In the US it is 50% of the market. Early stage penetration of extracts in the Canadian market is mostly due to the limited set products currently permitted for sale (oils, capsules and sprays).

SLIDE 5

BUSINESS MODEL.

Current facility of 5,000 sq. ft. with expansion to 8,000 sq. ft. underway EU-GMP facility will allow for international sales Initial capacity to achieve $5MM/month in revenue in Phase I Full funded expansion capacity to achieve $20MM/month in Phase II CO2 and solvent free extraction Ability for R&D and product formulation 34 SKUs

PROCESSING & EXTRACTION

SLIDE 6

THE FACILITY .

Current facility of 5,000 sq. ft. Phase I Expansion to 8,000 sq. ft. underway Building to EU-GMP certifications Dedicated lab and packaging spaces Provisional municipal license granted Modern CO2 extraction Designed with growth in mind. Easily scalable.

PURE EXTRACTS IS CURRENTLY EXPANDING FACILITY TO GMP SPECIFICATIONS

SLIDE 7

OUR EQUIPMENT .

HIGH-FLOW PUMP Industry leading speed FULL SPECTRUM EXTRACTION Maximum yield on every run COLD SEPARATION High-quality, undamaged product CO2 RECOVERY Recirculate solvent without delay PROCESS MANAGEMENT Fine tune operations for success FULLY CERTIFIED Federal safety certifications

INDUSTRY LEADING VITALIS CO2 EXTRACTORS

Q-Series & R-Series

SLIDE 8

BRANDING

Pure Pulls will be the first wave of extract brands to sell under Cannabis Act Top selling brand in Canada previously selling approx. *$800k/month

*unaudited historical sales of product under the Pure Pulls brand prior to the brand’s acquisition by Pure Extracts

BUSINESS MODEL.

SLIDE 9

PURE PULLS.

Best-selling brand across Canada. Established goodwill with a repeat customer base and brand loyalty. Revenue of approximately *$800k/month with 60% margin. Pure Pulls is one of the most widely recognized CO2 vape brands. Brand equity awareness developed through event sponsoring, and continual product education amongst our customer base. Industry leading distributor retention and renewals. Wide product line: 12 different strains, and 34 SKUs.

*unaudited historical sales of product under the Pure Pulls brand prior to the brand’s acquisition by Pure Extracts

FIRST BRAND TO BE SOLD UNDER THE CANADIAN CANNABIS ACT

SLIDE 10

A PROFITABLE FOCUSED BUSINESS PLAN.

QUALITY

Established brands known for quality Exceptionally low failure rate 100% product guarantees

DISTRIBUTION

Relationships in-place with leading dispensaries LOI’s in place with Licensed Producers for raw material supply

PHASE ONE

Over $5,000,000 in potential revenues *60% gross margins

EXPANSION

Phase II scales to $20MM/month Q1 2020 Fully funded within Use of Proceeds

LICENSE APPLIED

Standard Processing License anticipated Q4,2019 Grandfathered application (per Health Canada)

*unaudited historical sales of product under the Pure Pulls brand prior to the brand’s acquisition by Pure Extracts

SLIDE 11

MILESTONES.

PURE EXTRACTS HAS IMMEDIATE CATALYSTS UPCOMING AS IT EXPANDS UPON ITS EXISTING 5,000 SQ. FT. FACILITY AND ACHIEVES HEALTH CANADA LICENSING

Q3 2019

$10,000,000 IPO FINANCING AND CSE LISTING

Q4 2019

HEALTH CANADA STANDARD PROCESSING LICENSE GRANT & START OF SALES

Q3 2019

PHASE I EXPANSION TO 8,000 SQ. FT. COMPLETED

Q1 2020

PHASE II EXPANSION COMPLETE

SLIDE 12

COMPARABLES AND CAP TABLE.

Capitalization Valuation Statistics

Share Equity Enterprise 2020 2020 Enterprise Value / Company Name Ticker Price Value ($MM) Value ($MM) Capacity (kg) Revenue EBITDA Revenue EBITDA

Valens Grow Works VGW $4.16 506 456 240,000 137 63 3.3 x 7.2 x Medipharm Labs Corp LABS $5.33 692 617 150,000 213 67 2.9 x 9.3 x Neptune Wellness Solutions NEPT $5.76 468 468 30,000 65 15 7.2 x 30.8 x NextLeaf OILS $0.46 50 44 100,000 54 9 0.8 x 4.8 x Median $487 $462 125,000 101 39 3.11 x 8.24 x Pure Extracts $0.50 $35.0 $25.0 64,800 80 28 0.31 x 0.89 x Implied Valuation $248.73MM $230.85MM

Shares Value

Pure Extracts Pre-Money 50,833,334 $25,416,667 Financing @ $0.50 20,000,000 $10,000,000 Post-Money 70,833,334 $35,416,667

Comparable Companies ($ in thousands, except per share amounts) Share prices as of July 3, 2019; Valens, Medipharm and Neptune data is from the GMP research report “Extracting profits for concentrate returns” dated April 9, 2019. Nextleaf data is from the Ubika Alpha research report dated May 8, 2019.

SLIDE 13

PURE EXTRACTS CORP. 9387 EMERALD DRIVE WHISTLER, BC CANADA V8E 0G5 INFO@PUREEXTRACTSCORP.COM

THANK YOU

SLIDE 14

RIGHTS OF ACTION FOR PURCHASERS.

Securities legislation in Alberta, Saskatchewan, Manitoba, Ontario, Nova Scotia, New Brunswick, Newfoundland and Labrador, and Prince Edward Island provides investors in securities of the Company with certain rights of action where a presentation and any amendment to it contains a misrepresentation. These remedies, or notice with respect thereto, must be exercised or delivered, as the case may be, by the investor within the time limits prescribed by the applicable securities legislation. The following are summaries of these rights. Such summaries are subject to the express provisions of applicable securities legislation, and the rules, regulations and other instruments thereunder, and reference is made to the complete text of such provisions contained therein. Such provisions may contain certain limitations and statutory defences on which the Company and others may rely. These rights are in addition to, and without derogation from, any other right the investor may have at law. Investors should refer to the applicable provisions of the securities legislation of their province for the particulars of these rights or consult with a legal adviser. For purposes of the following summaries, “Misrepresentation” means an untrue statement of a material fact

r an omission to state a material fact that is necessary in order to make a statement not misleading in light
f the circumstances in which it was made.

Rights for Purchasers in Alberta Securities legislation in Alberta provides that every purchaser of securities in reliance on the exemption set forth in section 2.10 (the “minimum amount exemption”) of NI 45-106 pursuant to this presentation shall have, in addition to any other rights they may have at law, a right of action for damages or rescission against the Company and certain other persons if this presentation or any amendment thereto contains a misrepresentation. However, such rights must be exercised within prescribed time limits. Purchasers should refer to the applicable provisions of the Securities Act (Alberta) (the “Alberta Act”) for particulars of those rights or consult with a lawyer. Specifically, Section 204 of the Alberta Act provides that if this presentation, or any amendment to it, contains a misrepresentation (as defined in the Alberta Act), a purchaser who purchases securities offered by this presentation or any amendment shall be deemed to have relied on that misrepresentation, if it was a misrepresentation at the time of purchase, and has a right of action for damages against the Company, every director of the Company at the date of this presentation, and every person or company who signed this presentation or, alternatively, for rescission against the Company. If the purchaser exercises its right

f rescission against the Company, the purchaser will not have a right of action for damages against the

Company or against any aforementioned person or company. No such person or company is liable if it proves that the purchaser purchased the securities with knowledge of the misrepresentation. In an action for damages, the defendant will not be liable for all or any portion of the damages that it proves do not represent the depreciation in value of the securities as a result of the misrepresentation relied upon. The amount recoverable under this right of action will not exceed the price at which the securities are offered. In Alberta, no action shall be commenced to these rights of action more than: (a) in the case of an action for rescission, 180 days from the day of the transaction that gave rise to the cause of action; or (b) in the case of any action, other than an action for rescission, the earlier of: (i) 180 days from the day that the purchaser first had knowledge of the facts giving rise to the cause of action, or (ii) three years from the day of the transaction that gave rise to the cause of action. The foregoing summary is subject to the express provisions of the Alberta Act and the regulations promulgated thereunder and specific reference should be made to same. The rights of action for rescission or damages are in addition to, and without derogation from, any other right to the purchaser may have at law. Rights for Purchasers in Ontario In accordance with Section 130.1 of the Securities Act (Ontario) (the “Ontario Act”), in the event that this presentation or any amendment thereto contains a misrepresentation (as defined in the Ontario Act), the investor has, without regard to whether the investor relied upon the misrepresentation, a right of action against the Company for damages, or, while the investor is still the owner of the securities purchased by that investor, for rescission, in which case, if the investor elects to exercise the right of rescission, the investor will have no right of action for damages against the Company, provided that: (a) the Company will not be liable if it proves that the investor purchased the securities with knowledge of the misrepresentation; (b) in the case of an action for damages, the Company will not be liable for all or any portion of the damages that it proves do not represent the depreciation in value of the securities as a result of the misrepresentation relied upon; and (c) in no case will the amount recoverable in any action exceed the price at which the securities were sold to the investor. The foregoing rights provided in accordance with Section 130.1 of the Ontario Act do not apply to the following Investors relying upon the accredited investor exemption in Ontario: (a) a Canadian financial institution, meaning either (i) an association governed by the Cooperative Credit Associations Act (Canada) or a central cooperative credit society for which an order has been made under section 473(1) of that Act; or (ii) a bank, loan corporation, trust company, trust corporation, insurance company, treasury branch, credit union, caisse populaire, financial services corporation, or league that, in each case, is authorized by an enactment of Canada or a jurisdiction of Canada to carry on business in Canada or a jurisdiction in Canada; (b) a Schedule III bank, meaning an authorized foreign bank named in Schedule III of the Bank Act (Canada); (c) The Business Development Bank of Canada incorporated under the Business Development Bank of Canada Act (Canada); or a subsidiary of any person referred to in paragraphs (a), (b) or (c) if the person owns all of the voting securities of the subsidiary, except the voting securities required by law to be owned by the directors of the subsidiary. No action will be commenced to enforce these statutory rights more than: (a) in an action for rescission, 180 days from the date of the transaction that gave rise to the cause of action;

(b) in an action for damages, the earlier of: (i) 180 days after the plaintiff first had knowledge of the facts giving rise to the cause of action; or (ii) three years after the date of the transaction that gave rise to the cause of action. Rights for Purchasers in Ontario In accordance with Section 130.1 of the Securities Act (Ontario) (the “Ontario Act”), in the event that this presentation or any amendment thereto contains a misrepresentation (as defined in the Ontario Act), the investor has, without regard to whether the investor relied upon the misrepresentation, a right of action against the Company for damages, or, while the investor is still the owner of the securities purchased by that investor, for rescission, in which case, if the investor elects to exercise the right of rescission, the investor will have no right of action for damages against the Company, provided that: (a) the Company will not be liable if it proves that the investor purchased the securities with knowledge of the misrepresentation; (b) in the case of an action for damages, the Company will not be liable for all or any portion of the damages that it proves do not represent the depreciation in value of the securities as a result of the misrepresentation relied upon; and (c) in no case will the amount recoverable in any action exceed the price at which the securities were sold to the investor The foregoing rights provided in accordance with Section 130.1 of the Ontario Act do not apply to the following Investors relying upon the accredited investor exemption in Ontario: (d) a Canadian financial institution, meaning either (i) an association governed by the Cooperative Credit Associations Act (Canada) or a central cooperative credit society for which an order has been made under section 473(1) of that Act; or (ii) a bank, loan corporation, trust company, trust corporation, insurance company, treasury branch, credit union, caisse populaire, financial services corporation, or league that, in each case, is authorized by an enactment of Canada or a jurisdiction of Canada to carry on business in Canada or a jurisdiction in Canada; (e) a Schedule III bank, meaning an authorized foreign bank named in Schedule III of the Bank Act (Canada); (f) The Business Development Bank of Canada incorporated under the Business Development Bank of Canada Act (Canada); or a subsidiary of any person referred to in paragraphs (a), (b) or (c) if the person owns all of the voting securities of the subsidiary, except the voting securities required by law to be owned by the directors of the subsidiary. No action will be commenced to enforce these statutory rights more than: (g) in an action for rescission, 180 days from the date of the transaction that gave rise to the cause of action;

(h) in an action for damages, the earlier of: (i) 180 days after the plaintiff first had knowledge of the facts giving rise to the cause of action; or (ii) three years after the date of the transaction that gave rise to the cause of action. Investors in Saskatchewan, Manitoba, Nova Scotia, New Brunswick, Newfoundland and Labrador, Prince Edward Island: Click Here for your applicable statutory rights of action. General The foregoing summary is subject to the express provisions of the securities legislation in each of the provinces of Canada, and the regulations, rules and policy statements thereunder, and reference is made thereto for the complete text of such provisions. The rights of action described herein are in addition to and without derogation from any other right or remedy that the purchaser may have at law, and are subject to certain defences.